Cataract And Iol Hospital Profile
Key Indicators
- Authorised Capital ₹ 8.50 M
as on 23-12-2024
- Paid Up Capital ₹ 1.89 M
as on 23-12-2024
- Company Age 25 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.90 Cr
as on 23-12-2024
- Satisfied Charges ₹ 1.09 M
as on 23-12-2024
- Revenue 35.99%
(FY 2022)
- Profit 219.12%
(FY 2022)
- Ebitda 76.94%
(FY 2022)
- Net Worth 14.80%
(FY 2022)
- Total Assets 16.24%
(FY 2022)
About Cataract And Iol Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.50 M and a paid-up capital of Rs 1.89 M.
The company currently has active open charges totaling ₹1.90 Cr. The company has closed loans amounting to ₹1.09 M, as per Ministry of Corporate Affairs (MCA) records.
Narayan Bordoloi, Ranjumoni Bordoloi, and Saswat Bordoloi serve as directors at the Company.
- CIN/LLPIN
U85110AS1999PTC005658
- Company No.
005658
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Feb 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Jorhat, Assam, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cataract And Iol Hospital?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narayan Bordoloi  | Managing Director | 10-Feb-1999 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ranjumoni Bordoloi | Director | 30-Jan-2003 | Current |
| Saswat Bordoloi | Director | 07-Feb-2019 | Current |
Financial Performance of Cataract And Iol Hospital.
Cataract And Iol Hospital Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 35.99% increase. The company also saw a substantial improvement in profitability, with a 219.12% increase in profit. The company's net worth Soared by an impressive increase of 14.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cataract And Iol Hospital?
In 2020, Cataract And Iol Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 Mar 2023 | ₹2.50 M | Open |
State Bank Of India Creation Date: 27 Jan 2023 | ₹5.10 M | Open |
Others Creation Date: 24 Jan 2023 | ₹4.00 M | Open |
How Many Employees Work at Cataract And Iol Hospital?
Unlock and access historical data on people associated with Cataract And Iol Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cataract And Iol Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cataract And Iol Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
